Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
38.1%
0%
38.1%
6 Months
8.75%
0%
8.75%
1 Year
-40.0%
0%
-40.0%
2 Years
-76.49%
0%
-76.49%
3 Years
-59.53%
0%
-59.53%
4 Years
-86.08%
0%
-86.08%
5 Years
-91.71%
0%
-91.71%
IQ-AI Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
7.86%
EBIT Growth (5y)
10.80%
EBIT to Interest (avg)
-0.48
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.05
Sales to Capital Employed (avg)
0.55
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.40
EV to EBIT
-1.32
EV to EBITDA
-1.32
EV to Capital Employed
1.32
EV to Sales
1.32
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-14.24%
ROE (Latest)
-14.24%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
Bullish
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
0.60
0.50
20.00%
Operating Profit (PBDIT) excl Other Income
-0.30
-0.40
25.00%
Interest
0.00
0.00
Exceptional Items
-0.20
0.00
Consolidate Net Profit
-0.60
-0.50
-20.00%
Operating Profit Margin (Excl OI)
-666.80%
-934.70%
26.79%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is 20.00% vs 0.00% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is -20.00% vs 0.00% in Dec 2022
About IQ-AI Ltd. 
IQ-AI Ltd.
Software Products
IQ-AI Limited, formerly Flying Brands Limited, is a Jersey-based medical services and software company. The Company provides health care technology solutions to the artificial intelligence (AI) medical imaging market. Through its subsidiary, StoneChecker Software Ltd, It offers medical imaging software for urolithiasis that analyses and presents stone metrics, including stone size, volume, density, skin to stone distance, and stone architecture through TexRAD analysis within the healthcare information technology (IT) systems. Through its subsidiary, Imaging Biometrics, LLC, It specializes in the design and manufacture of visualization tools, the application of machine learning and AI software solutions, and the development and clinical testing of imaging endpoints and biomarkers. Its portfolio consists of IB Neuro and IB Diffusion that are used in treatment of brain tumors, strokes and pathologies.
Company Coordinates 
Company Details
La Rue De La Frontiere, Retreat Farm , SAINT HELIER None : JE4 8TQ
Registrar Details






